A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma
Clinical trial NCT03184987 · COMPLETED
Trial details
- NCT number
- NCT03184987
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-22
- Primary completion
- 2019-06-25
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.